What the analyst said
UBS analyst Karl Keirstead reiterated a Buy rating and $105 price target on CoreWeave (NASDAQ: CRWV).
“CoreWeave shares are indicated +8% post what we conclude was a solid overall print that addressed many of the credit/funding as well as ROIC issues that have weighed heavily on the stock over the last month. Revs (+168% to $3.7b) and non-GAAP OMs (of 10%) in 3Q26 landed above the guide, the full year 2027 guide was inched up, the commentary about revs/MW and demand (2027 capacity is sold out) was very bullish and CoreWeave presented a financing plan that enables them to avoid the unsecured (parent-level) debt market entirely. We remain Buy-rated.”
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.
This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.
Where the price stands
CRWV trades at $39.51. The 28 analysts who set a target in the last 3 months range from $39 to $200, with a median of $111. This $105 target is 5% below the median.
Since the note CRWV has moved −19% (from $48.73). 12-month window: day 9 of 365, closes on November 11, 2027.
Track record
This callOpen: CRWV has not reached $105 yet. This 12-month target is scored on October 23, 2027. Same target as this firm’s October 23, 2026 note, so it is scored there.
Firm track recordUBS: 83% of its 59 targets at least a year old were reached within 12 months (#4 of 29 firms). Accuracy ranking →
UBS on CoreWeave
UBS price targets on CoreWeave
3 calls from September 23, 2026 to November 11, 2026. The target went from $120 to $105 (−13%). The rating stayed Buy.
- November 11, 2026 This noteKept the $105 targetBuy$105
- October 23, 2026Target cut from $120 (−13%)Buy$105
- September 23, 2026Earliest call shownBuy$120






